Article
Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens
2020-05-13
Abstract excerpt
<h4>Background</h4> Several point-of-care (POC) molecular tests have received emergency use authorization (EUA) from the Food and Drug Administration (FDA) for diagnosis of SARS-CoV-2. The test performance characteristics of the Accula (Mesa Biotech) SARS-CoV-2 POC test need to be evaluated to inform its optimal use. <h4>Objectives</h4> The aim of this study was to assess test performance of the Accula SARS-CoV-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 93995ec6-f8b3-5581-a7ec-970ec5ceb65f
- DOI
- 10.1101/2020.05.12.092379
